🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marı́a del Monte-Millán

Hospital General Universitario Gregorio Marañón

ORCID: 0000-0002-4499-5906

Also affiliated with Centro de Investigación Biomédica en Red de Cáncer

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study”.

356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study

Annals of Oncology(2023)10.1016/j.annonc.2023.09.535
N/A
0DataRank · unranked
1 citations

Helena Earl, Christina Yau, David Cameron, Jean Abraham, Larry Hayward +15 more

TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy

Annals of Oncology(2024)10.1016/j.annonc.2024.10.012
N/A
0DataRank · unranked
31 citations

S.R. Stecklein, Oleg Gluz, Guillermo Villacampa, Marı́a del Monte-Millán, Ulrike Nitz +42 more

Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf162
N/A
0DataRank · unranked
1 citations

Miguel Martín, Guillermo Villacampa, Marı́a del Monte-Millán, Rachel Yoder, Harsh B. Pathak +23 more